EPC080 | Systematic review and meta-analyses of the interaction between HIV infection and COVID-19: two years' evidence summary | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC081 | Clinical and demographic characteristics of tuberculosis patients in health care facilities in Botswana: a retrospective analysis | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC082 | Declining trends of HIV and syphilis seroprevalence at integrated counselling and testing centre in a tertiary care hospital in North India: a six year study | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC083 | Prevalence of non-communicable diseases among HIV-infected persons in sub-Saharan Africa: a systematic review | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC084 | High prevalence of anal high-risk human papillomavirus infectionin HIV-negative French men who have sex with men during 12 months of Pre-exposure prophylaxis uptake:potential efficacy of Gardasil-9® vaccination | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC085 | Scale-up of tuberculosis preventive therapy among people living with HIV in Uganda: initiation, completion, and TB disease notification rates, April 2017'September 2021 | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC086 | HPV prevalence and risk factors in HIV-negative and HIV-positive South Africa adolescent girls: results from the HOPE study | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
EPC087 | High incidence of HIV and STIs in late pregnancy: compelling evidence for repeat etiological testing | E-poster | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
OAC0203 | The impact of COVID-19 non-pharmaceutical interventions on incidence and case-fatality ratios of sexually transmitted diseases in China | Oral abstract session with live Q&A | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |
PESAC11 | Declining incidence of chlamydia and gonorrhea, but not mycoplasma in a high-risk population eligible for PrEP experiencing a test-and-treat-setting | Poster exhibition | Epidemiology of non-AIDS infections and communicable diseases (e.g., viral hepatitis, STIs, TB, COVID-19) |